Skip to content

Clinical trials

Observational Amyloidosis trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Phase: Observational Status: Unknown status Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20202
20214
20222
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris1
Beneficência Portuguesa de São Paulo1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla1
Heidelberg University1
Heinrich-Heine University, Duesseldorf1
John Paul II Hospital, Krakow1
National Center for Research Resources (NCRR)1
Oregon Health and Science University1
Sanguine Biosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis13
Amyloid Neuropathies, Familial3
Cardiomyopathies3
Aortic Valve Stenosis2
Arthritis2
Alopecia Areata1
Alzheimer Disease1
Anemia, Sickle Cell1
Asthma1
Autistic Disorder1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.